We’re so excited! Neuland Labs just received a huge award – the 2013 CMO Leadership Award in the Regulatory category from Life Science Leader magazine. It’s an honor to have our strengths in regulatory reporting and processing recognized by our customers & industry leaders. And it is even more meaningful especially because of the emphasis we place on regulatory excellence.

We believe that quality matters. Consistent with our record of cGMP excellence, our last two FDA inspections had no Form 483 citations issued. Given that in 2010 the FDA issued nearly 10,000 Form 483 warnings recording non-compliance with the FDA’s cGMP standards, we’re proud of our record of regulatory excellence…and I’m proud of our team’s commitment to quality.

As an API and contract pharmaceutical manufacturer that serves customers in 85 countries, we have to be constantly vigilant about regulatory matters. It’s why – since the early days – one of our driving goals has been quality-consciousness. And it’s why we’ll continue to build on our record of regulatory excellence as we move towards the future.

Read the press release to learn more about the CMO Leadership Awards.

Attending CPhI? Learn more about our regulatory excellence in person!

If you’ll be at CPhI’s worldwide conference in Frankfurt, Germany on Oct 21-24, stop by Booth #30B32 and learn more about our 30-year history of quality & regulatory excellence.

At CPhI, Neuland Labs will be sponsoring one of the Pre-Connect Conferences on October 21st – Module D: API Sourcing in Emerging Markets – at 1:00 p.m.  In this session, API sourcing from India and China – as well as the potential of emerging markets as new sourcing destinations – will be discussed. The Pre-Connect Conference is the go-to destination for some serious networking at CPhI, so don’t miss it!